ANCN

ANCN Stock: Speculation Around Investor Letter Sends Anchiano Therapeutics Soaring

By William White, InvestorPlace Writer
Anchiano Therapeutics (ANCN) stock is rocketing higher on Monday after a shareholder letter caught the interest of investors.

ANCN Stock: 10 Things to Know as Anchiano Therapeutics Rockets Higher

By Chris MacDonald, InvestorPlace Contributor
ANCN stock is an early stage company engaged in clinical trials for rare liver, lung and skin diseases with no FDA-approved options now.

ANCN Stock: Why Anchiano Therapeutics Stock Is Blasting Higher Today

By William White, InvestorPlace Writer
Anchiano Therapeutics (ANCN) stock is soaring higher on Tuesday following news of a merger with Chemomab that will bring major changes.